NSAID (NON-STEROIDAL ANTI-INFLAMMATORY DRUG)

Clinical trials for NSAID (NON-STEROIDAL ANTI-INFLAMMATORY DRUG) explained in plain language.

Never miss a new study

Get alerted when new NSAID (NON-STEROIDAL ANTI-INFLAMMATORY DRUG) trials appear

Sign up with your email to follow new studies for NSAID (NON-STEROIDAL ANTI-INFLAMMATORY DRUG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New pill aims to shield stomachs from painkiller damage

Prevention Not yet recruiting

This study tests whether a new medicine called Fexuprazan can prevent stomach ulcers in people who need to take NSAID pain relievers (like ibuprofen) for at least 24 weeks. About 360 adults with joint or muscle pain will receive either Fexuprazan or an older ulcer-prevention drug…

Matched conditions: NSAID (NON-STEROIDAL ANTI-INFLAMMATORY DRUG)

Phase: PHASE4 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Prevention

Last updated May 11, 2026 20:50 UTC

NSAID (NON-STEROIDAL ANTI-INFLAMMATORY DRUG)

Get alerted when new NSAID (NON-STEROIDAL ANTI-INFLAMMATORY DRUG) trials appear

New pill aims to shield stomachs from painkiller damage